데이터 상품 상세검색

[감염병연구]

폐질환·폐암(편평상피세포암) 환자 의료 및 인산화단백체 데이터

폐질환·폐암(편평상피세포암) 환자 의료 및 인산화단백체 데이터

  • 등록일2022-12-16
  • 조회수391
  • 다운로드282
  • 카테고리감염병연구
  • 10

데이터 기본 이용료

  • 5,000,000원
상세정보
데이터등록일 데이터 수정일 데이터 이용기한 판매제공처
2022-12-16 2023-07-05 무기한 셀키
데이터 제공포맷 데이터 제공방식 데이터 파일용량 데이터 상품구분
csv/zip 다운로드 3.91 GB dataset

● 데이터 상품명 폐질환·폐암(편평상피세포암) 환자 의료 및 인산화단백체 데이터 ● 데이터 상품 부제 암 특화 임상 및 인산화단백체 데이터와 의료데이터 ● 데이터 상품 요약 미국 국립암연구소 (NCI), 가톨릭대학교 의과대학의 폐질환·폐암(선암) 의료 및 단백체 정성·정량 분석 결과 ● 데이터 상품 정보 ■ 상품 설명 및 특징 - 국내 최초·최대 암 관련 (관련 질병 포함) 당 단백질 질량분석 실험 데이터의 해석 및 당·단백질 리포지토리를 구축하고 정밀의료 연구기술에 발전시키고자 함 - 참여 병원으로부터 제공된 폐질환 폐암(선암) 환자 시료를 전처리하여 고분해능 질량분석기기를 통해 최적화된 분석을 진행하고 당사에서 자체 개발한 분석솔루션 SpAC9 Pipeline을 활용하여 데이터분석 등의 프로세스를 통하여 표준화 기준에 맞춰 최종 데이터를 가공, 생산함 - NCI 의 CPTAC에서 제공된 질량분석이 완료된 선암 RAW 데이터는 SpAC9 Pipeline을 활용하여 재분석하고 표준화 기준에 맞춰 데이터를 가공·생산함 ■ 기간 및 범위 - 2022년 9월 ~ 2022년 10월 ■ 컬럼(속성) 정보 - 집계시작년월 : 2022년 9월 - 집계시작년월 : 2022년 10월 ■ 약어/전문용어 설명 - NCI: National Cancer Institute - CPTAC: Clinical Proteome Tumor Analysis Consortium ■ 활용 예제 - 시스템 확대·발전 - 의료 및 단백체 빅데이터 고도화를 위한 유전단백체 변이 아틀라스 구축으로 시스템 확대 및 발전 - 인간의 유전단백체 변이 아틀라스를 구축하여 질병 별로 유전자 변이가 단백질의 변이를 일으키는 경우의 데이터베이스 구축하여 질병의 이해와 개인 맞춤형 신약 개발 및 진단 발굴 사업에 필요한 데이터를 제공

샘플정보
그룹명
결과파일명
결과ID
질량분석기기분석일자
생성일자
수정일자
ID
환자ID
샘플ID
암코드
분석정보
샘플타입
환자나이
환자성별
환자인종
환자민족인종
환자종양위치
환자종양크기
병리학적종양타입명
병리학적종양등급
종양병소
종양측향화
병리학적병기분류
환자국적
종양괴사
병리학적진단
종양분화도
간경변병력
간결절크기
간염병력
B형간염표면항원
B형간염코어항체
프로트롬빈함량
빌리루빈함량
알부민함량
알라닌아미노전이효소함량
감마글루타밀전이효소함량
알파태아단백질함량
아스파르테이트아미노전달효소함량
알칼리인산분해효소함량
TNM병기분류
BCLC병기분류
AJCC병기분류
원발성종양병리학적상태
림프절전이병리학적상태
타장기전이병리학적상태
종양전이범위
암진단이력
치료이력
잔여종양병리학적상태
음주량
흡연이력
흡연나이
금연나이
하루흡연량
연간흡연량
12개월간종양크기
24개월간종양크기
유전자심볼
단백질심볼
단백질명
펩타이드명
펩타이드질량
펩타이드전하
펩타이드스캔1ID
펩타이드스캔2ID
펩타이드값
펩타이드함량
11CPTAC_LSCC_Phosphoproteome_BI_20190802 11CPTAC_LSCC_P_BI_20190802_BD_f10.raw CPTAC_Phosphoproteome 20200812 20221201 3712543 C3N-00221 LUSC Tumor_and_Normal 78 Male Not Reported Not-Hispanic or Latino Middle Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage III Other: TSS did not collect this information Seventh Edition (2010) pT3 pN0 No pathologic evidence of distant metastasis Staging Incomplete DCN NP_001911.1(pre=R,post=V) decorin isoform a preproprotein GN=DCN AHENEITK__0 467.2699 3 11846 11847 62.0 1391470000.0
11CPTAC_LSCC_Phosphoproteome_BI_20190802 11CPTAC_LSCC_P_BI_20190802_BD_f10.raw CPTAC_Phosphoproteome 20200812 20221201 3712544 C3L-04013 LUSC Tumor_and_Normal 61 Male Other 8 Squamous cell carcinoma G3 Poorly differentiated Stage IIB Bulgaria Seventh Edition (2010) pT3 pN0 Staging Incomplete Staging Incomplete DCN NP_001911.1(pre=R,post=V) decorin isoform a preproprotein GN=DCN AHENEITK__0 467.2699 3 11846 11847 62.0 1391470000.0
11CPTAC_LSCC_Phosphoproteome_BI_20190802 11CPTAC_LSCC_P_BI_20190802_BD_f10.raw CPTAC_Phosphoproteome 20200812 20221201 3712545 C3L-00568 LUSC Tumor_and_Normal 74 Female White Hispanic or Latino Upper Lobe 5 Squamous cell carcinoma G2 Moderately differentiated Stage IB United States Seventh Edition (2010) pT2a pN0 Staging Incomplete Staging Incomplete DCN NP_001911.1(pre=R,post=V) decorin isoform a preproprotein GN=DCN AHENEITK__0 467.2699 3 11846 11847 62.0 1391470000.0
13CPTAC_LSCC_Phosphoproteome_BI_20190806 13CPTAC_LSCC_P_BI_20190806_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 5584603 C3L-02170 LUSC Tumor 73 Male Lower Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IB Bulgaria Seventh Edition (2010) pT2a pN0 Staging Incomplete Staging Incomplete NHS NP_001278796.1(pre=K,post=R) Nance-Horan syndrome protein isoform 3 GN=NHS LAGLASPSSGYSSQSETPTSSFPTAFFSGPLSPGGSK_LAGLAS[0.00]PS[0.00]S[0.00]GY[0.00]S[0.00]S[0.00]QS[0.00]ET[0.00]PT[0.00]S[0.00]S[0.00]FPT[0.00]AFFS[0.00]GPLS[99.99]PGGS[0.01]K_1 1033.2584 4 46458 46466 39.0 0.0
13CPTAC_LSCC_Phosphoproteome_BI_20190806 13CPTAC_LSCC_P_BI_20190806_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 5584604 C3L-01285 LUSC Tumor_and_Normal 54 Male White Not-Hispanic or Latino Upper Lobe 5 Squamous cell carcinoma G2 Moderately differentiated Stage IIA United States Seventh Edition (2010) pT2a pN1 Staging Incomplete Staging Incomplete NHS NP_001278796.1(pre=K,post=R) Nance-Horan syndrome protein isoform 3 GN=NHS LAGLASPSSGYSSQSETPTSSFPTAFFSGPLSPGGSK_LAGLAS[0.00]PS[0.00]S[0.00]GY[0.00]S[0.00]S[0.00]QS[0.00]ET[0.00]PT[0.00]S[0.00]S[0.00]FPT[0.00]AFFS[0.00]GPLS[99.99]PGGS[0.01]K_1 1033.2584 4 46458 46466 39.0 0.0
13CPTAC_LSCC_Phosphoproteome_BI_20190806 13CPTAC_LSCC_P_BI_20190806_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 5584605 C3L-00993 LUSC Tumor_and_Normal 75 Male Lower Lobe 6 Squamous cell carcinoma G2 Moderately differentiated Stage IIIA Ukraine Seventh Edition (2010) pT2b pN2 No pathologic evidence of distant metastasis cM0 NHS NP_001278796.1(pre=K,post=R) Nance-Horan syndrome protein isoform 3 GN=NHS LAGLASPSSGYSSQSETPTSSFPTAFFSGPLSPGGSK_LAGLAS[0.00]PS[0.00]S[0.00]GY[0.00]S[0.00]S[0.00]QS[0.00]ET[0.00]PT[0.00]S[0.00]S[0.00]FPT[0.00]AFFS[0.00]GPLS[99.99]PGGS[0.01]K_1 1033.2584 4 46458 46466 39.0 0.0
14CPTAC_LSCC_Phosphoproteome_BI_20190809 14CPTAC_LSCC_P_BI_20190809_BD_f03.raw CPTAC_Phosphoproteome 20200812 20221201 6093157 C3N-03093 LUSC Tumor_and_Normal 70 Female Squamous cell carcinoma G3 Poorly differentiated Ukraine UBN1 NP_001072982.1(pre=R,post=E) ubinuclein-1 isoform a GN=UBN1 QASESEDDFIK_QAS[100]ES[100]EDDFIK_2 943.9116 2 29245 29247 64.0 2597870000.0
14CPTAC_LSCC_Phosphoproteome_BI_20190809 14CPTAC_LSCC_P_BI_20190809_BD_f03.raw CPTAC_Phosphoproteome 20200812 20221201 6093407 C3N-03093 LUSC Tumor_and_Normal 70 Female Squamous cell carcinoma G3 Poorly differentiated Ukraine DEK NP_003463.1(pre=D,post=K) protein DEK isoform 1 GN=DEK SSDDEPLIK_S[100]S[100]DDEPLIK_2 811.378 2 29493 29502 59.0 186030000.0
14CPTAC_LSCC_Phosphoproteome_BI_20190809 14CPTAC_LSCC_P_BI_20190809_BD_f03.raw CPTAC_Phosphoproteome 20200812 20221201 6093589 C3N-00555 LUSC Tumor_and_Normal 59 Male Middle Lobe 6 Squamous cell carcinoma G2 Moderately differentiated Stage IIB Vietnam Seventh Edition (2010) pT3 pN0 Staging Incomplete cM0 NP_001025062.1(pre=R,post=D) SYDVPPPPMEPDHPFYSNISK_S[50.00]Y[50.00]DVPPPPMEPDHPFY[0.00]S[0.00]NIS[0.00]K_1 991.1295 3 29707 29714 66.0 93633900.0
14CPTAC_LSCC_Phosphoproteome_BI_20190809 14CPTAC_LSCC_P_BI_20190809_BD_f03.raw CPTAC_Phosphoproteome 20200812 20221201 6093590 C3L-01455 LUSC Tumor_and_Normal 88 Male White Not-Hispanic or Latino Lower Lobe 5 Squamous cell carcinoma G3 Poorly differentiated Stage IIA United States Seventh Edition (2010) pT2a pN1 Staging Incomplete Staging Incomplete NP_001025062.1(pre=R,post=D) SYDVPPPPMEPDHPFYSNISK_S[50.00]Y[50.00]DVPPPPMEPDHPFY[0.00]S[0.00]NIS[0.00]K_1 991.1295 3 29707 29714 66.0 93633900.0
14CPTAC_LSCC_Phosphoproteome_BI_20190809 14CPTAC_LSCC_P_BI_20190809_BD_f03.raw CPTAC_Phosphoproteome 20200812 20221201 6093591 C3L-02624 LUSC Tumor_and_Normal 63 Male Upper Lobe 4 Squamous cell carcinoma G3 Poorly differentiated Stage IB Bulgaria Seventh Edition (2010) pT2a pN0 Staging Incomplete Staging Incomplete NP_001025062.1(pre=R,post=D) SYDVPPPPMEPDHPFYSNISK_S[50.00]Y[50.00]DVPPPPMEPDHPFY[0.00]S[0.00]NIS[0.00]K_1 991.1295 3 29707 29714 66.0 93633900.0
14CPTAC_LSCC_Phosphoproteome_BI_20190809 14CPTAC_LSCC_P_BI_20190809_BD_f03.raw CPTAC_Phosphoproteome 20200812 20221201 6093592 C3N-03093 LUSC Tumor_and_Normal 70 Female Squamous cell carcinoma G3 Poorly differentiated Ukraine NP_001025062.1(pre=R,post=D) SYDVPPPPMEPDHPFYSNISK_S[50.00]Y[50.00]DVPPPPMEPDHPFY[0.00]S[0.00]NIS[0.00]K_1 991.1295 3 29707 29714 66.0 93633900.0
14CPTAC_LSCC_Phosphoproteome_BI_20190809 14CPTAC_LSCC_P_BI_20190809_BD_f03.raw CPTAC_Phosphoproteome 20200812 20221201 6093593 C3N-01893 LUSC Tumor_and_Normal 70 Male Upper Lobe 5 Squamous cell carcinoma G2 Moderately differentiated Stage IIIA Poland Eighth Edition (2017) pT3 pN1 pM0 cM0 NP_001025062.1(pre=R,post=D) SYDVPPPPMEPDHPFYSNISK_S[50.00]Y[50.00]DVPPPPMEPDHPFY[0.00]S[0.00]NIS[0.00]K_1 991.1295 3 29707 29714 66.0 93633900.0
09CPTAC_LSCC_Phosphoproteome_BI_20190729 09CPTAC_LSCC_P_BI_20190729_BD_f11.raw CPTAC_Phosphoproteome 20200812 20221201 2820010 C3L-02130 LUSC Tumor_and_Normal 70 Male Upper Lobe 3 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IB Bulgaria Seventh Edition (2010) pT2a pN0 Staging Incomplete Staging Incomplete PAM NP_001306872.1(pre=R,post=K) peptidyl-glycine alpha-amidating monooxygenase isoform f precursor GN=PAM GKGSGGLNLGNFFASR_GKGS[100.00]GGLNLGNFFAS[0.00]R_1 707.3742 3 35301 35306 80.0 2778180000.0
09CPTAC_LSCC_Phosphoproteome_BI_20190729 09CPTAC_LSCC_P_BI_20190729_BD_f11.raw CPTAC_Phosphoproteome 20200812 20221201 2820011 C3N-02675 LUSC Tumor_and_Normal 69 Male Upper Lobe 2 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIIA Poland Seventh Edition (2010) pT3 pN2 Staging Incomplete Staging Incomplete REPS1 NP_001273540.1(pre=R,post=M) ralBP1-associated Eps domain-containing protein 1 isoform c GN=REPS1 SSSSQTLTQFDSNIAPADPDTAIVHPVPIR_S[0.65]S[0.65]S[32.46]S[32.46]QT[32.46]LT[0.65]QFDS[0.65]NIAPADPDT[0.00]AIVHPVPIR_1 869.1841 4 35301 35307 113.0 3147730000.0
09CPTAC_LSCC_Phosphoproteome_BI_20190729 09CPTAC_LSCC_P_BI_20190729_BD_f11.raw CPTAC_Phosphoproteome 20200812 20221201 2820012 C3N-02523 LUSC Tumor_and_Normal 61 Male White Not-Hispanic or Latino Lower Lobe 2 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IA United States Eighth Edition (2017) pT1b pN0 Not identified cM0 REPS1 NP_001273540.1(pre=R,post=M) ralBP1-associated Eps domain-containing protein 1 isoform c GN=REPS1 SSSSQTLTQFDSNIAPADPDTAIVHPVPIR_S[0.65]S[0.65]S[32.46]S[32.46]QT[32.46]LT[0.65]QFDS[0.65]NIAPADPDT[0.00]AIVHPVPIR_1 869.1841 4 35301 35307 113.0 3147730000.0
09CPTAC_LSCC_Phosphoproteome_BI_20190729 09CPTAC_LSCC_P_BI_20190729_BD_f11.raw CPTAC_Phosphoproteome 20200812 20221201 2820013 C3N-02426 LUSC Tumor_and_Normal 69 Female Lower Lobe 2 Other G3 Poorly differentiated Stage IA China Seventh Edition (2010) pT1a pN0 Staging Incomplete cM0 REPS1 NP_001273540.1(pre=R,post=M) ralBP1-associated Eps domain-containing protein 1 isoform c GN=REPS1 SSSSQTLTQFDSNIAPADPDTAIVHPVPIR_S[0.65]S[0.65]S[32.46]S[32.46]QT[32.46]LT[0.65]QFDS[0.65]NIAPADPDT[0.00]AIVHPVPIR_1 869.1841 4 35301 35307 113.0 3147730000.0
21CPTAC_LSCC_Phosphoproteome_BI_20190905 21CPTAC_LSCC_P_BI_20190905_BD_f10.raw CPTAC_Phosphoproteome 20200812 20221201 2850419 C3L-02163 LUSC Tumor_and_Normal 57 Male Upper Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIA Bulgaria Seventh Edition (2010) pT2 pN1 Staging Incomplete Staging Incomplete TBC1D16 NP_061893.2(pre=K,post=R) TBC1 domain family member 16 isoform a GN=TBC1D16 LPSSETHPEESMYK_LPS[33.33]S[33.33]ET[33.33]HPEES[0.00]MY[0.00]K_1 730.3469 3 18197 18199 58.0 2033400000.0
21CPTAC_LSCC_Phosphoproteome_BI_20190905 21CPTAC_LSCC_P_BI_20190905_BD_f10.raw CPTAC_Phosphoproteome 20200812 20221201 2850420 C3L-00904 LUSC Tumor_and_Normal 71 Male White Not-Hispanic or Latino Lower Lobe 4 Squamous cell carcinoma G3 Poorly differentiated Stage IIB United States Seventh Edition (2010) pT3 pN0 Staging Incomplete cM0 TBC1D16 NP_061893.2(pre=K,post=R) TBC1 domain family member 16 isoform a GN=TBC1D16 LPSSETHPEESMYK_LPS[33.33]S[33.33]ET[33.33]HPEES[0.00]MY[0.00]K_1 730.3469 3 18197 18199 58.0 2033400000.0
11CPTAC_LSCC_Phosphoproteome_BI_20190802 11CPTAC_LSCC_P_BI_20190802_BD_f05.raw CPTAC_Phosphoproteome 20200812 20221201 3475786 C3N-04155 LUSC Tumor_and_Normal 76 Male Middle Lobe 3 Non-keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IA Ukraine Seventh Edition (2010) pT1b pN0 Staging Incomplete cM0 CEP170B NP_001106197.1(pre=R,post=G) centrosomal protein of 170 kDa protein B isoform 1 GN=CEP170B SPQEGPTWSR_S[100.00]PQEGPT[0.00]WS[0.00]R_1 727.335 2 19746 19752 104.0 411255000.0
11CPTAC_LSCC_Phosphoproteome_BI_20190802 11CPTAC_LSCC_P_BI_20190802_BD_f05.raw CPTAC_Phosphoproteome 20200812 20221201 3475787 C3N-01025 LUSC Tumor_and_Normal 52 Male Other 10 Squamous cell carcinoma G3 Poorly differentiated Stage IIB Vietnam Seventh Edition (2010) pT3 pN0 Staging Incomplete cM0 CEP170B NP_001106197.1(pre=R,post=G) centrosomal protein of 170 kDa protein B isoform 1 GN=CEP170B SPQEGPTWSR_S[100.00]PQEGPT[0.00]WS[0.00]R_1 727.335 2 19746 19752 104.0 411255000.0
11CPTAC_LSCC_Phosphoproteome_BI_20190802 11CPTAC_LSCC_P_BI_20190802_BD_f05.raw CPTAC_Phosphoproteome 20200812 20221201 3475788 C3N-00221 LUSC Tumor_and_Normal 78 Male Not Reported Not-Hispanic or Latino Middle Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage III Other: TSS did not collect this information Seventh Edition (2010) pT3 pN0 No pathologic evidence of distant metastasis Staging Incomplete CEP170B NP_001106197.1(pre=R,post=G) centrosomal protein of 170 kDa protein B isoform 1 GN=CEP170B SPQEGPTWSR_S[100.00]PQEGPT[0.00]WS[0.00]R_1 727.335 2 19746 19752 104.0 411255000.0
11CPTAC_LSCC_Phosphoproteome_BI_20190802 11CPTAC_LSCC_P_BI_20190802_BD_f05.raw CPTAC_Phosphoproteome 20200812 20221201 3475789 C3L-04013 LUSC Tumor_and_Normal 61 Male Other 8 Squamous cell carcinoma G3 Poorly differentiated Stage IIB Bulgaria Seventh Edition (2010) pT3 pN0 Staging Incomplete Staging Incomplete CEP170B NP_001106197.1(pre=R,post=G) centrosomal protein of 170 kDa protein B isoform 1 GN=CEP170B SPQEGPTWSR_S[100.00]PQEGPT[0.00]WS[0.00]R_1 727.335 2 19746 19752 104.0 411255000.0
11CPTAC_LSCC_Phosphoproteome_BI_20190802 11CPTAC_LSCC_P_BI_20190802_BD_f05.raw CPTAC_Phosphoproteome 20200812 20221201 3475791 C3N-04155 LUSC Tumor_and_Normal 76 Male Middle Lobe 3 Non-keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IA Ukraine Seventh Edition (2010) pT1b pN0 Staging Incomplete cM0 MAGED2 NP_055414.2(pre=K,post=D) melanoma-associated antigen D2 GN=MAGED2 LQSSQEPEAPPPR_LQS[1.59]S[98.41]QEPEAPPPR_1 872.9261 2 19746 19759 92.0 0.0
22CPTAC_LSCC_Phosphoproteome_BI_20190907 22CPTAC_LSCC_P_BI_20190907_BD_f12.raw CPTAC_Phosphoproteome 20200812 20221201 4509626 C3N-03851 LUSC Tumor_and_Normal 44 Male Upper Lobe 5 Squamous cell carcinoma G3 Poorly differentiated Stage IIB China Eighth Edition (2017) pT2b pN1 pM0 cM0 MAP3K11 NP_002410.1(pre=R,post=R) mitogen-activated protein kinase kinase kinase 11 GN=MAP3K11 IDPWSFVSAGPRPSPLPSPQPAPR_IDPWS[0.00]FVS[0.00]AGPRPS[0.07]PLPS[99.92]PQPAPR_1 955.826 3 39096 39097 146.0 248761000.0
22CPTAC_LSCC_Phosphoproteome_BI_20190907 22CPTAC_LSCC_P_BI_20190907_BD_f12.raw CPTAC_Phosphoproteome 20200812 20221201 4509627 C3N-01892 LUSC Tumor_and_Normal 77 Male Upper Lobe 7 Non-keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIB Poland Eighth Edition (2017) pT3 pN0 pM0 cM0 MAP3K11 NP_002410.1(pre=R,post=R) mitogen-activated protein kinase kinase kinase 11 GN=MAP3K11 IDPWSFVSAGPRPSPLPSPQPAPR_IDPWS[0.00]FVS[0.00]AGPRPS[0.07]PLPS[99.92]PQPAPR_1 955.826 3 39096 39097 146.0 248761000.0
22CPTAC_LSCC_Phosphoproteome_BI_20190907 22CPTAC_LSCC_P_BI_20190907_BD_f12.raw CPTAC_Phosphoproteome 20200812 20221201 4509628 C3L-03965 LUSC Tumor_and_Normal 54 Male Other 4 Squamous cell carcinoma G2 Moderately differentiated Stage IIIA Bulgaria Seventh Edition (2010) pT2b pN2 Staging Incomplete Staging Incomplete MAP3K11 NP_002410.1(pre=R,post=R) mitogen-activated protein kinase kinase kinase 11 GN=MAP3K11 IDPWSFVSAGPRPSPLPSPQPAPR_IDPWS[0.00]FVS[0.00]AGPRPS[0.07]PLPS[99.92]PQPAPR_1 955.826 3 39096 39097 146.0 248761000.0
13CPTAC_LSCC_Phosphoproteome_BI_20190806 13CPTAC_LSCC_P_BI_20190806_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 5585619 C3L-01285 LUSC Tumor_and_Normal 54 Male White Not-Hispanic or Latino Upper Lobe 5 Squamous cell carcinoma G2 Moderately differentiated Stage IIA United States Seventh Edition (2010) pT2a pN1 Staging Incomplete Staging Incomplete LRRC8B NP_001127948.1(pre=W,post=L) volume-regulated anion channel subunit LRRC8B GN=LRRC8B TTRALSETVAEQSVRPLK_T[92.33]T[92.33]RALS[7.67]ET[7.67]VAEQS[100.00]VRPLK_3 671.8353 4 51148 51153 52.0 0.0
04CPTAC_LSCC_Phosphoproteome_BI_20190705 04CPTAC_LSCC_P_BI_20190705_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 5578341 C3N-03662 LUSC Tumor_and_Normal 64 Male Middle Lobe 4 Non-keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIA Ukraine Seventh Edition (2010) pT2a pN1 Staging Incomplete cM0 TTC9 NP_056166.1(pre=R,post=L) tetratricopeptide repeat protein 9A GN=TTC9 DSRPASPAGALKPGR_DS[0.00]RPAS[100.00]PAGALKPGR_1 673.3696 3 14409 14413 50.0 2093940000.0
04CPTAC_LSCC_Phosphoproteome_BI_20190705 04CPTAC_LSCC_P_BI_20190705_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 5578342 C3N-03072 LUSC Tumor_and_Normal 62 Male Upper Lobe 3 Squamous cell carcinoma G3 Poorly differentiated Stage IIIA China Eighth Edition (2017) pT2a pN2 pM0 cM0 TTC9 NP_056166.1(pre=R,post=L) tetratricopeptide repeat protein 9A GN=TTC9 DSRPASPAGALKPGR_DS[0.00]RPAS[100.00]PAGALKPGR_1 673.3696 3 14409 14413 50.0 2093940000.0
04CPTAC_LSCC_Phosphoproteome_BI_20190705 04CPTAC_LSCC_P_BI_20190705_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 5578343 C3N-02252 LUSC Tumor_and_Normal 68 Female White Not-Hispanic or Latino Squamous cell carcinoma G3 Poorly differentiated Other: unknown TTC9 NP_056166.1(pre=R,post=L) tetratricopeptide repeat protein 9A GN=TTC9 DSRPASPAGALKPGR_DS[0.00]RPAS[100.00]PAGALKPGR_1 673.3696 3 14409 14413 50.0 2093940000.0
04CPTAC_LSCC_Phosphoproteome_BI_20190705 04CPTAC_LSCC_P_BI_20190705_BD_f10.raw CPTAC_Phosphoproteome 20200812 20221201 5728686 C3N-03662 LUSC Tumor_and_Normal 64 Male Middle Lobe 4 Non-keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIA Ukraine Seventh Edition (2010) pT2a pN1 Staging Incomplete cM0 BPTF NP_872579.2(pre=K,post=L) nucleosome-remodeling factor subunit BPTF isoform 1 GN=BPTF SLTSATSTSNIQSSASQPPRPQQGQVK_S[14.29]LT[14.29]S[14.29]AT[14.29]S[14.29]T[14.29]S[14.29]NIQS[0.00]S[0.00]AS[0.00]QPPRPQQGQVK_1 831.6792 4 19474 19477 115.0 292948000.0
04CPTAC_LSCC_Phosphoproteome_BI_20190705 04CPTAC_LSCC_P_BI_20190705_BD_f10.raw CPTAC_Phosphoproteome 20200812 20221201 5728687 C3N-03072 LUSC Tumor_and_Normal 62 Male Upper Lobe 3 Squamous cell carcinoma G3 Poorly differentiated Stage IIIA China Eighth Edition (2017) pT2a pN2 pM0 cM0 BPTF NP_872579.2(pre=K,post=L) nucleosome-remodeling factor subunit BPTF isoform 1 GN=BPTF SLTSATSTSNIQSSASQPPRPQQGQVK_S[14.29]LT[14.29]S[14.29]AT[14.29]S[14.29]T[14.29]S[14.29]NIQS[0.00]S[0.00]AS[0.00]QPPRPQQGQVK_1 831.6792 4 19474 19477 115.0 292948000.0
04CPTAC_LSCC_Phosphoproteome_BI_20190705 04CPTAC_LSCC_P_BI_20190705_BD_f10.raw CPTAC_Phosphoproteome 20200812 20221201 5728688 C3N-02252 LUSC Tumor_and_Normal 68 Female White Not-Hispanic or Latino Squamous cell carcinoma G3 Poorly differentiated Other: unknown BPTF NP_872579.2(pre=K,post=L) nucleosome-remodeling factor subunit BPTF isoform 1 GN=BPTF SLTSATSTSNIQSSASQPPRPQQGQVK_S[14.29]LT[14.29]S[14.29]AT[14.29]S[14.29]T[14.29]S[14.29]NIQS[0.00]S[0.00]AS[0.00]QPPRPQQGQVK_1 831.6792 4 19474 19477 115.0 292948000.0
04CPTAC_LSCC_Phosphoproteome_BI_20190705 04CPTAC_LSCC_P_BI_20190705_BD_f10.raw CPTAC_Phosphoproteome 20200812 20221201 5728702 C3N-03072 LUSC Tumor_and_Normal 62 Male Upper Lobe 3 Squamous cell carcinoma G3 Poorly differentiated Stage IIIA China Eighth Edition (2017) pT2a pN2 pM0 cM0 PIK3AP1 NP_689522.2(pre=R,post=V) phosphoinositide 3-kinase adapter protein 1 GN=PIK3AP1 SRSPGPPQVDGTPTMSLERPPR_S[50.00]RS[50.00]PGPPQVDGT[0.00]PT[0.00]MS[0.00]LERPPR_1 668.5831 4 19474 19478 139.0 770263000.0
09CPTAC_LSCC_Phosphoproteome_BI_20190729 09CPTAC_LSCC_P_BI_20190729_BD_f11.raw CPTAC_Phosphoproteome 20200812 20221201 2821013 C3N-02426 LUSC Tumor_and_Normal 69 Female Lower Lobe 2 Other G3 Poorly differentiated Stage IA China Seventh Edition (2010) pT1a pN0 Staging Incomplete cM0 STOML1 NP_004800.2(pre=R,post=G) stomatin-like protein 1 isoform 1 GN=STOML1 FQQSSFGFLGSQK_FQQS[2.13]S[95.74]FGFLGS[2.13]QK_1 667.0095 3 37000 37007 82.0 256585000.0
09CPTAC_LSCC_Phosphoproteome_BI_20190729 09CPTAC_LSCC_P_BI_20190729_BD_f11.raw CPTAC_Phosphoproteome 20200812 20221201 2820938 C3N-02426 LUSC Tumor_and_Normal 69 Female Lower Lobe 2 Other G3 Poorly differentiated Stage IA China Seventh Edition (2010) pT1a pN0 Staging Incomplete cM0 ACIN1 NP_055792.1(pre=K,post=E) apoptotic chromatin condensation inducer in the nucleus isoform 1 GN=ACIN1 KASLVALPEQTASEEETPPPLLTK_KAS[100.00]LVALPEQT[0.00]AS[0.00]EEET[0.00]PPPLLT[0.00]K_1 829.9647 4 36853 36856 65.0 1685000000.0
09CPTAC_LSCC_Phosphoproteome_BI_20190729 09CPTAC_LSCC_P_BI_20190729_BD_f11.raw CPTAC_Phosphoproteome 20200812 20221201 2820939 C3N-02284 LUSC Tumor 69 Male Mainstem bronchus 5 Squamous cell carcinoma G2 Moderately differentiated Stage IIB Poland Eighth Edition (2017) pT3 pN0 pM0 cM0 ACIN1 NP_055792.1(pre=K,post=E) apoptotic chromatin condensation inducer in the nucleus isoform 1 GN=ACIN1 KASLVALPEQTASEEETPPPLLTK_KAS[100.00]LVALPEQT[0.00]AS[0.00]EEET[0.00]PPPLLT[0.00]K_1 829.9647 4 36853 36856 65.0 1685000000.0
09CPTAC_LSCC_Phosphoproteome_BI_20190729 09CPTAC_LSCC_P_BI_20190729_BD_f11.raw CPTAC_Phosphoproteome 20200812 20221201 2820940 C3L-02130 LUSC Tumor_and_Normal 70 Male Upper Lobe 3 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IB Bulgaria Seventh Edition (2010) pT2a pN0 Staging Incomplete Staging Incomplete ACIN1 NP_055792.1(pre=K,post=E) apoptotic chromatin condensation inducer in the nucleus isoform 1 GN=ACIN1 KASLVALPEQTASEEETPPPLLTK_KAS[100.00]LVALPEQT[0.00]AS[0.00]EEET[0.00]PPPLLT[0.00]K_1 829.9647 4 36853 36856 65.0 1685000000.0
09CPTAC_LSCC_Phosphoproteome_BI_20190729 09CPTAC_LSCC_P_BI_20190729_BD_f11.raw CPTAC_Phosphoproteome 20200812 20221201 2820941 C3N-02675 LUSC Tumor_and_Normal 69 Male Upper Lobe 2 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIIA Poland Seventh Edition (2010) pT3 pN2 Staging Incomplete Staging Incomplete ELF2 NP_001317965.1(pre=K,post=V) ETS-related transcription factor Elf-2 isoform 6 GN=ELF2 ISTVAVQSVNAGAPLITSTSPTTATSPK_IS[0.00]T[0.00]VAVQS[0.00]VNAGAPLIT[0.00]S[0.00]T[0.00]S[0.00]PT[0.00]T[0.00]AT[0.09]S[99.91]PK_1 810.1934 4 36866 36868 70.0 351952000.0
09CPTAC_LSCC_Phosphoproteome_BI_20190729 09CPTAC_LSCC_P_BI_20190729_BD_f11.raw CPTAC_Phosphoproteome 20200812 20221201 2820942 C3N-02523 LUSC Tumor_and_Normal 61 Male White Not-Hispanic or Latino Lower Lobe 2 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IA United States Eighth Edition (2017) pT1b pN0 Not identified cM0 ELF2 NP_001317965.1(pre=K,post=V) ETS-related transcription factor Elf-2 isoform 6 GN=ELF2 ISTVAVQSVNAGAPLITSTSPTTATSPK_IS[0.00]T[0.00]VAVQS[0.00]VNAGAPLIT[0.00]S[0.00]T[0.00]S[0.00]PT[0.00]T[0.00]AT[0.09]S[99.91]PK_1 810.1934 4 36866 36868 70.0 351952000.0
21CPTAC_LSCC_Phosphoproteome_BI_20190905 21CPTAC_LSCC_P_BI_20190905_BD_f10.raw CPTAC_Phosphoproteome 20200812 20221201 2850869 C3L-02163 LUSC Tumor_and_Normal 57 Male Upper Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIA Bulgaria Seventh Edition (2010) pT2 pN1 Staging Incomplete Staging Incomplete SRPRA NP_003130.2(pre=I,post=G) signal recognition particle receptor subunit alpha isoform 1 GN=SRPRA RGTGSGGQLQDLDCSSSDDEGAAQNSTKPSATK_RGT[0.06]GS[0.06]GGQLQDLDCS[99.91]S[99.99]S[99.99]DDEGAAQNS[0.00]T[0.00]KPS[0.00]AT[0.00]K_3 1063.9722 4 18944 18945 108.0 2052010000.0
13CPTAC_LSCC_Phosphoproteome_BI_20190806 13CPTAC_LSCC_P_BI_20190806_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 5570682 C3L-02627 LUSC Tumor_and_Normal 64 Female Lower Lobe 2 Squamous cell carcinoma G3 Poorly differentiated Stage IA Bulgaria Seventh Edition (2010) pT1 pN0 Staging Incomplete cM0 GAPDH NP_001276674.1(pre=R,post=Y) glyceraldehyde-3-phosphate dehydrogenase isoform 1 GN=GAPDH VIISAPSADAPMFVMGVNHEK_VIIS[50.00]APS[50.00]ADAPMFVMGVNHEK_1 917.8068 3 38550 38556 71.0 8618450.0
13CPTAC_LSCC_Phosphoproteome_BI_20190806 13CPTAC_LSCC_P_BI_20190806_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 5570683 C3L-02170 LUSC Tumor 73 Male Lower Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IB Bulgaria Seventh Edition (2010) pT2a pN0 Staging Incomplete Staging Incomplete GAPDH NP_001276674.1(pre=R,post=Y) glyceraldehyde-3-phosphate dehydrogenase isoform 1 GN=GAPDH VIISAPSADAPMFVMGVNHEK_VIIS[50.00]APS[50.00]ADAPMFVMGVNHEK_1 917.8068 3 38550 38556 71.0 8618450.0
13CPTAC_LSCC_Phosphoproteome_BI_20190806 13CPTAC_LSCC_P_BI_20190806_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 5570684 C3L-01285 LUSC Tumor_and_Normal 54 Male White Not-Hispanic or Latino Upper Lobe 5 Squamous cell carcinoma G2 Moderately differentiated Stage IIA United States Seventh Edition (2010) pT2a pN1 Staging Incomplete Staging Incomplete GAPDH NP_001276674.1(pre=R,post=Y) glyceraldehyde-3-phosphate dehydrogenase isoform 1 GN=GAPDH VIISAPSADAPMFVMGVNHEK_VIIS[50.00]APS[50.00]ADAPMFVMGVNHEK_1 917.8068 3 38550 38556 71.0 8618450.0
14CPTAC_LSCC_Phosphoproteome_BI_20190809 14CPTAC_LSCC_P_BI_20190809_BD_f10.raw CPTAC_Phosphoproteome 20200812 20221201 6976007 C3N-03093 LUSC Tumor_and_Normal 70 Female Squamous cell carcinoma G3 Poorly differentiated Ukraine PGM2 NP_060760.2(pre=K,post=Q) phosphoglucomutase-2 GN=PGM2 LCAGIMITASHNPK_LCAGIMIT[0.00]AS[100.00]HNPK_1 684.3563 3 26958 26959 84.0 251965000000.0
10CPTAC_LSCC_Phosphoproteome_BI_20190731 10CPTAC_LSCC_P_BI_20190731_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 3086863 C3L-02951 LUSC Tumor_and_Normal 61 Male White Not-Hispanic or Latino Lower Lobe 5 Non-keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIA United States Eighth Edition (2017) pT2b pN0 No pathologic evidence of distant metastasis unknown MS4A1 NP_068769.2(pre=R,post=E) B-lymphocyte antigen CD20 GN=MS4A1 RMSSLVGPTQSFFMR_RMS[100.00]S[100.00]LVGPT[0.00]QS[0.00]FFMR_2 716.9902 3 36438 36443 69.0 926960000.0
10CPTAC_LSCC_Phosphoproteome_BI_20190731 10CPTAC_LSCC_P_BI_20190731_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 3086864 C3L-02629 LUSC Tumor_and_Normal 57 Male Lower Lobe 8 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIB Bulgaria Seventh Edition (2010) pT3 pN0 Staging Incomplete cM0 MS4A1 NP_068769.2(pre=R,post=E) B-lymphocyte antigen CD20 GN=MS4A1 RMSSLVGPTQSFFMR_RMS[100.00]S[100.00]LVGPT[0.00]QS[0.00]FFMR_2 716.9902 3 36438 36443 69.0 926960000.0
10CPTAC_LSCC_Phosphoproteome_BI_20190731 10CPTAC_LSCC_P_BI_20190731_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 3086865 C3L-00923 LUSC Tumor_and_Normal 71 Female White Not-Hispanic or Latino Upper Lobe 4 Squamous cell carcinoma G3 Poorly differentiated Stage IB United States Seventh Edition (2010) pT2a pN0 No pathologic evidence of distant metastasis cM0 MS4A1 NP_068769.2(pre=R,post=E) B-lymphocyte antigen CD20 GN=MS4A1 RMSSLVGPTQSFFMR_RMS[100.00]S[100.00]LVGPT[0.00]QS[0.00]FFMR_2 716.9902 3 36438 36443 69.0 926960000.0
10CPTAC_LSCC_Phosphoproteome_BI_20190731 10CPTAC_LSCC_P_BI_20190731_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 3086866 C3N-04127 LUSC Tumor_and_Normal 63 Male Lower Lobe 5 Squamous cell carcinoma G2 Moderately differentiated Stage IIIA China Eighth Edition (2017) pT2b pN2 pM0 cM0 LIMCH1 NP_001317601.1(pre=R,post=Y) LIM and calponin homology domains-containing protein 1 isoform h GN=LIMCH1 SHSTEPNLSSFLNDPNPMK_S[0.86]HS[0.86]T[0.86]EPNLS[48.71]S[48.71]FLNDPNPMK_1 885.0961 3 36447 36448 90.0 8152030000.0
12CPTAC_LSCC_Phosphoproteome_BI_20190804 12CPTAC_LSCC_P_BI_20190804_BD_f10.raw CPTAC_Phosphoproteome 20200812 20221201 4652778 C3L-02660 LUSC Tumor_and_Normal 72 Male Other 3 Keratinizing squamous cell carcinoma G3 Poorly differentiated Stage IIIA Bulgaria Seventh Edition (2010) pT2a pN2 Staging Incomplete cM0 CTTN NP_001171669.1(pre=K,post=A) src substrate cortactin isoform c GN=CTTN TQTPPVSPAPQPTEERLPSSPVYEDAASFK_T[33.33]QT[33.33]PPVS[33.33]PAPQPT[0.00]EERLPS[0.00]S[0.00]PVY[0.00]EDAAS[0.00]FK_1 941.9683 4 33106 33120 56.0 88379600000.0
12CPTAC_LSCC_Phosphoproteome_BI_20190804 12CPTAC_LSCC_P_BI_20190804_BD_f10.raw CPTAC_Phosphoproteome 20200812 20221201 4652779 C3L-02552 LUSC Tumor_and_Normal 68 Male White Not-Hispanic or Latino Lower Lobe 4 Other G3 Poorly differentiated Stage IB United States Seventh Edition (2010) pT2a pN0 No pathologic evidence of distant metastasis Staging Incomplete CTTN NP_001171669.1(pre=K,post=A) src substrate cortactin isoform c GN=CTTN TQTPPVSPAPQPTEERLPSSPVYEDAASFK_T[33.33]QT[33.33]PPVS[33.33]PAPQPT[0.00]EERLPS[0.00]S[0.00]PVY[0.00]EDAAS[0.00]FK_1 941.9683 4 33106 33120 56.0 88379600000.0
12CPTAC_LSCC_Phosphoproteome_BI_20190804 12CPTAC_LSCC_P_BI_20190804_BD_f10.raw CPTAC_Phosphoproteome 20200812 20221201 4652780 C3L-01884 LUSC Tumor_and_Normal 74 Male White Not-Hispanic or Latino Upper Lobe 3 Squamous cell carcinoma G2 Moderately differentiated Stage IA United States Seventh Edition (2010) pT1b pN0 No pathologic evidence of distant metastasis cM0 CTTN NP_001171669.1(pre=K,post=A) src substrate cortactin isoform c GN=CTTN TQTPPVSPAPQPTEERLPSSPVYEDAASFK_T[33.33]QT[33.33]PPVS[33.33]PAPQPT[0.00]EERLPS[0.00]S[0.00]PVY[0.00]EDAAS[0.00]FK_1 941.9683 4 33106 33120 56.0 88379600000.0
15CPTAC_LSCC_Phosphoproteome_BI_20190812 15CPTAC_LSCC_P_BI_20190812_BD_f06.raw CPTAC_Phosphoproteome 20200812 20221201 1261813 C3N-02283 LUSC Tumor 67 Male Upper Lobe 4 Other GX Grade cannot be assessed Stage IIB Poland Eighth Edition (2017) pT2b pN1 pM0 cM0 NP_001306115.1(pre=A,post=E) GDLLEDSPKRPK_GDLLEDS[100]PKRPK_1 708.0682 3 19121 19124 52.0 2099660000.0
20CPTAC_LSCC_Phosphoproteome_BI_20190902 20CPTAC_LSCC_P_BI_20190902_BD_f07.raw CPTAC_Phosphoproteome 20200812 20221201 744643 C3L-04014 LUSC Tumor_and_Normal 57 Male Lower Lobe 2 Squamous cell carcinoma G3 Poorly differentiated Stage IA Bulgaria Seventh Edition (2010) pT1 pN0 Staging Incomplete Staging Incomplete TP53BP1 NP_001135452.1(pre=R,post=G) TP53-binding protein 1 isoform 1 GN=TP53BP1 TSSGTSLSAMHSSGSSGK_T[19.93]S[19.93]S[19.93]GT[19.93]S[19.93]LS[0.36]AMHS[0.00]S[0.00]GS[0.00]S[0.00]GK_1 741.683 3 10204 10206 102.0 406297000.0
20CPTAC_LSCC_Phosphoproteome_BI_20190902 20CPTAC_LSCC_P_BI_20190902_BD_f07.raw CPTAC_Phosphoproteome 20200812 20221201 744644 C3L-02891 LUSC Tumor_and_Normal 66 Female White Not-Hispanic or Latino Other 3 Squamous cell carcinoma G3 Poorly differentiated Stage IIA United States Eighth Edition (2017) pT1c pN1 unknown unknown TP53BP1 NP_001135452.1(pre=R,post=G) TP53-binding protein 1 isoform 1 GN=TP53BP1 TSSGTSLSAMHSSGSSGK_T[19.93]S[19.93]S[19.93]GT[19.93]S[19.93]LS[0.36]AMHS[0.00]S[0.00]GS[0.00]S[0.00]GK_1 741.683 3 10204 10206 102.0 406297000.0
20CPTAC_LSCC_Phosphoproteome_BI_20190902 20CPTAC_LSCC_P_BI_20190902_BD_f07.raw CPTAC_Phosphoproteome 20200812 20221201 744645 C3L-00927 LUSC Tumor_and_Normal 74 Male White Not-Hispanic or Latino Lower Lobe 4 Squamous cell carcinoma G2 Moderately differentiated Stage IIIA United States Seventh Edition (2010) pT2a pN2 No pathologic evidence of distant metastasis cM0 TP53BP1 NP_001135452.1(pre=R,post=G) TP53-binding protein 1 isoform 1 GN=TP53BP1 TSSGTSLSAMHSSGSSGK_T[19.93]S[19.93]S[19.93]GT[19.93]S[19.93]LS[0.36]AMHS[0.00]S[0.00]GS[0.00]S[0.00]GK_1 741.683 3 10204 10206 102.0 406297000.0
21CPTAC_LSCC_Phosphoproteome_BI_20190905 21CPTAC_LSCC_P_BI_20190905_BD_f11.raw CPTAC_Phosphoproteome 20200812 20221201 2953432 C3N-03425 LUSC Tumor_and_Normal 64 Female Upper Lobe 3 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IB Poland Seventh Edition (2010) pT2a pN0 No pathologic evidence of distant metastasis cM0 MARF1 NP_001171927.1(pre=R,post=E) meiosis regulator and mRNA stability factor 1 isoform 2 GN=MARF1 SKSPVGNPQLIQFSR_S[0.02]KS[99.98]PVGNPQLIQFS[0.00]R_1 732.7368 3 24915 24920 101.0 4303550000.0
21CPTAC_LSCC_Phosphoproteome_BI_20190905 21CPTAC_LSCC_P_BI_20190905_BD_f11.raw CPTAC_Phosphoproteome 20200812 20221201 2953433 C3N-00211 LUSC Tumor 40 Male Middle Lobe 5 Squamous cell carcinoma G3 Poorly differentiated Stage IIIA Bulgaria Seventh Edition (2010) pT2a pN2 Staging Incomplete cM0 MARF1 NP_001171927.1(pre=R,post=E) meiosis regulator and mRNA stability factor 1 isoform 2 GN=MARF1 SKSPVGNPQLIQFSR_S[0.02]KS[99.98]PVGNPQLIQFS[0.00]R_1 732.7368 3 24915 24920 101.0 4303550000.0
21CPTAC_LSCC_Phosphoproteome_BI_20190905 21CPTAC_LSCC_P_BI_20190905_BD_f11.raw CPTAC_Phosphoproteome 20200812 20221201 2953441 C3N-04124 LUSC Tumor_and_Normal 62 Male Upper Lobe 4 Squamous cell carcinoma G3 Poorly differentiated Stage IB China Eighth Edition (2017) pT2a pN0 pM0 cM0 ZFC3H1 NP_659419.3(pre=R,post=K) zinc finger C3H1 domain-containing protein GN=ZFC3H1 RISTSDILSEK_RIS[99.03]T[0.96]S[0.01]DILS[0.00]EK_1 596.3291 3 24915 24922 70.0 1647400000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 371489 C3L-03678 LUSC Tumor 49 Male White Not-Hispanic or Latino Lower Lobe 4 Squamous cell carcinoma G3 Poorly differentiated Stage IIIA United States Seventh Edition (2010) pT2a pN2 No pathologic evidence of distant metastasis cM0 ZC3H18 NP_001281269.1(pre=R,post=E) zinc finger CCCH domain-containing protein 18 isoform 1 GN=ZC3H18 GPTSSPCEEEGDEGEEDRTSDLRDEASSVTR_GPT[33.33]S[33.33]S[33.33]PCEEEGDEGEEDRT[4.33]S[95.67]DLRDEAS[0.00]S[0.00]VT[0.00]R_2 1262.85 3 19952 19953 52.0 638588000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 371490 C3L-02648 LUSC Tumor_and_Normal 72 Male Other 3 Squamous cell carcinoma G3 Poorly differentiated Stage IIA Bulgaria Seventh Edition (2010) pT2 pN0 Staging Incomplete Staging Incomplete ZC3H18 NP_001281269.1(pre=R,post=E) zinc finger CCCH domain-containing protein 18 isoform 1 GN=ZC3H18 GPTSSPCEEEGDEGEEDRTSDLRDEASSVTR_GPT[33.33]S[33.33]S[33.33]PCEEEGDEGEEDRT[4.33]S[95.67]DLRDEAS[0.00]S[0.00]VT[0.00]R_2 1262.85 3 19952 19953 52.0 638588000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 371491 C3N-01194 LUSC Tumor_and_Normal 69 Male Lower Lobe 4 Non-keratinizing squamous cell carcinoma G3 Poorly differentiated Stage IA Poland Seventh Edition (2010) pT2a pN0 No pathologic evidence of distant metastasis cM0 VAPB NP_004729.1(pre=K,post=S) vesicle-associated membrane protein-associated protein B/C isoform 1 GN=VAPB TETPIVSK_T[0.00]ET[1.05]PIVS[98.95]K_1 706.8945 2 19952 19955 81.0 386726000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 371492 C3N-01020 LUSC Tumor_and_Normal 65 Male Other 4 Squamous cell carcinoma G3 Poorly differentiated Stage IB Vietnam Seventh Edition (2010) pT2a pN0 Staging Incomplete cM0 VAPB NP_004729.1(pre=K,post=S) vesicle-associated membrane protein-associated protein B/C isoform 1 GN=VAPB TETPIVSK_T[0.00]ET[1.05]PIVS[98.95]K_1 706.8945 2 19952 19955 81.0 386726000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 371493 C3N-00497 LUSC Tumor_and_Normal 64 Female Middle Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIB Poland Seventh Edition (2010) pT2b pN1 No pathologic evidence of distant metastasis cM0 VAPB NP_004729.1(pre=K,post=S) vesicle-associated membrane protein-associated protein B/C isoform 1 GN=VAPB TETPIVSK_T[0.00]ET[1.05]PIVS[98.95]K_1 706.8945 2 19952 19955 81.0 386726000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 371494 C3L-03678 LUSC Tumor 49 Male White Not-Hispanic or Latino Lower Lobe 4 Squamous cell carcinoma G3 Poorly differentiated Stage IIIA United States Seventh Edition (2010) pT2a pN2 No pathologic evidence of distant metastasis cM0 VAPB NP_004729.1(pre=K,post=S) vesicle-associated membrane protein-associated protein B/C isoform 1 GN=VAPB TETPIVSK_T[0.00]ET[1.05]PIVS[98.95]K_1 706.8945 2 19952 19955 81.0 386726000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 371552 C3N-01020 LUSC Tumor_and_Normal 65 Male Other 4 Squamous cell carcinoma G3 Poorly differentiated Stage IB Vietnam Seventh Edition (2010) pT2a pN0 Staging Incomplete cM0 NP_000692.2(pre=R,post=T) GIVVYTGDR_GIVVY[99.98]T[0.02]GDR_1 644.8302 2 20013 20014 85.0 722491000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 372486 C3N-01194 LUSC Tumor_and_Normal 69 Male Lower Lobe 4 Non-keratinizing squamous cell carcinoma G3 Poorly differentiated Stage IA Poland Seventh Edition (2010) pT2a pN0 No pathologic evidence of distant metastasis cM0 CAMK2D NP_001212.2(pre=K,post=A) calcium/calmodulin-dependent protein kinase type II subunit delta isoform 3 GN=CAMK2D KPDGVKESTESSNTTIEDEDVK_KPDGVKES[49.12]T[49.12]ES[33.15]S[33.15]NT[1.76]T[33.70]IEDEDVK_2 1162.2462 3 21073 21076 55.0 2541270.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 373492 C3N-01020 LUSC Tumor_and_Normal 65 Male Other 4 Squamous cell carcinoma G3 Poorly differentiated Stage IB Vietnam Seventh Edition (2010) pT2a pN0 Staging Incomplete cM0 SAFB NP_001188267.1(pre=K,post=V) scaffold attachment factor B1 isoform 1 GN=SAFB RSVVSFDK_RS[0.00]VVS[100.00]FDK_1 738.4034 2 22420 22422 86.0 213293000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 374486 C3N-01194 LUSC Tumor_and_Normal 69 Male Lower Lobe 4 Non-keratinizing squamous cell carcinoma G3 Poorly differentiated Stage IA Poland Seventh Edition (2010) pT2a pN0 No pathologic evidence of distant metastasis cM0 SSRP1 NP_003137.1(pre=K,post=M) FACT complex subunit SSRP1 GN=SSRP1 EGMNPSYDEYADSDEDQHDAYLER_EGMNPS[2.50]Y[2.50]DEY[95.00]ADS[100.00]DEDQHDAY[0.00]LER_2 1080.0767 3 23725 23728 96.0 221540000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 374487 C3N-01020 LUSC Tumor_and_Normal 65 Male Other 4 Squamous cell carcinoma G3 Poorly differentiated Stage IB Vietnam Seventh Edition (2010) pT2a pN0 Staging Incomplete cM0 SSRP1 NP_003137.1(pre=K,post=M) FACT complex subunit SSRP1 GN=SSRP1 EGMNPSYDEYADSDEDQHDAYLER_EGMNPS[2.50]Y[2.50]DEY[95.00]ADS[100.00]DEDQHDAY[0.00]LER_2 1080.0767 3 23725 23728 96.0 221540000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 374488 C3N-00497 LUSC Tumor_and_Normal 64 Female Middle Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIB Poland Seventh Edition (2010) pT2b pN1 No pathologic evidence of distant metastasis cM0 SSRP1 NP_003137.1(pre=K,post=M) FACT complex subunit SSRP1 GN=SSRP1 EGMNPSYDEYADSDEDQHDAYLER_EGMNPS[2.50]Y[2.50]DEY[95.00]ADS[100.00]DEDQHDAY[0.00]LER_2 1080.0767 3 23725 23728 96.0 221540000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 376487 C3N-01020 LUSC Tumor_and_Normal 65 Male Other 4 Squamous cell carcinoma G3 Poorly differentiated Stage IB Vietnam Seventh Edition (2010) pT2a pN0 Staging Incomplete cM0 NASP NP_002473.2(pre=K,post=A) nuclear autoantigenic sperm protein isoform 2 GN=NASP QEPEVNGGSGDAVPSGNEVSENMEEEAENQAESR_QEPEVNGGS[2.30]GDAVPS[95.40]GNEVS[2.30]ENMEEEAENQAES[0.00]R_1 1295.5609 3 26229 26246 107.0 53943900.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 376488 C3N-00497 LUSC Tumor_and_Normal 64 Female Middle Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIB Poland Seventh Edition (2010) pT2b pN1 No pathologic evidence of distant metastasis cM0 NASP NP_002473.2(pre=K,post=A) nuclear autoantigenic sperm protein isoform 2 GN=NASP QEPEVNGGSGDAVPSGNEVSENMEEEAENQAESR_QEPEVNGGS[2.30]GDAVPS[95.40]GNEVS[2.30]ENMEEEAENQAES[0.00]R_1 1295.5609 3 26229 26246 107.0 53943900.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 376489 C3L-03678 LUSC Tumor 49 Male White Not-Hispanic or Latino Lower Lobe 4 Squamous cell carcinoma G3 Poorly differentiated Stage IIIA United States Seventh Edition (2010) pT2a pN2 No pathologic evidence of distant metastasis cM0 NASP NP_002473.2(pre=K,post=A) nuclear autoantigenic sperm protein isoform 2 GN=NASP QEPEVNGGSGDAVPSGNEVSENMEEEAENQAESR_QEPEVNGGS[2.30]GDAVPS[95.40]GNEVS[2.30]ENMEEEAENQAES[0.00]R_1 1295.5609 3 26229 26246 107.0 53943900.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 379474 C3L-03678 LUSC Tumor 49 Male White Not-Hispanic or Latino Lower Lobe 4 Squamous cell carcinoma G3 Poorly differentiated Stage IIIA United States Seventh Edition (2010) pT2a pN2 No pathologic evidence of distant metastasis cM0 KDM2A NP_036440.1(pre=R,post=G) lysine-specific demethylase 2A isoform a GN=KDM2A SCDEPLTPPPHSPTSMLQLIHDPVSPR_S[50.37]CDEPLT[50.37]PPPHS[33.06]PT[33.10]S[33.10]MLQLIHDPVS[0.00]PR_2 1138.5238 3 29887 29900 41.0 311177000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 379475 C3L-02648 LUSC Tumor_and_Normal 72 Male Other 3 Squamous cell carcinoma G3 Poorly differentiated Stage IIA Bulgaria Seventh Edition (2010) pT2 pN0 Staging Incomplete Staging Incomplete KDM2A NP_036440.1(pre=R,post=G) lysine-specific demethylase 2A isoform a GN=KDM2A SCDEPLTPPPHSPTSMLQLIHDPVSPR_S[50.37]CDEPLT[50.37]PPPHS[33.06]PT[33.10]S[33.10]MLQLIHDPVS[0.00]PR_2 1138.5238 3 29887 29900 41.0 311177000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 379476 C3N-01194 LUSC Tumor_and_Normal 69 Male Lower Lobe 4 Non-keratinizing squamous cell carcinoma G3 Poorly differentiated Stage IA Poland Seventh Edition (2010) pT2a pN0 No pathologic evidence of distant metastasis cM0 KDM2A NP_036440.1(pre=R,post=G) lysine-specific demethylase 2A isoform a GN=KDM2A SCDEPLTPPPHSPTSMLQLIHDPVSPR_S[50.37]CDEPLT[50.37]PPPHS[33.06]PT[33.10]S[33.10]MLQLIHDPVS[0.00]PR_2 1138.5238 3 29887 29900 41.0 311177000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 381468 C3N-00497 LUSC Tumor_and_Normal 64 Female Middle Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIB Poland Seventh Edition (2010) pT2b pN1 No pathologic evidence of distant metastasis cM0 DACT3 NP_659493.2(pre=R,post=L) dapper homolog 3 isoform 1 GN=DACT3 AWASSWESEAAPEPAAPPAAPSPPDSPAEGR_AWAS[0.00]S[0.00]WES[0.00]EAAPEPAAPPAAPS[100.00]PPDS[0.00]PAEGR_1 1132.5197 3 32616 32620 97.0 407235000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 381469 C3L-03678 LUSC Tumor 49 Male White Not-Hispanic or Latino Lower Lobe 4 Squamous cell carcinoma G3 Poorly differentiated Stage IIIA United States Seventh Edition (2010) pT2a pN2 No pathologic evidence of distant metastasis cM0 DACT3 NP_659493.2(pre=R,post=L) dapper homolog 3 isoform 1 GN=DACT3 AWASSWESEAAPEPAAPPAAPSPPDSPAEGR_AWAS[0.00]S[0.00]WES[0.00]EAAPEPAAPPAAPS[100.00]PPDS[0.00]PAEGR_1 1132.5197 3 32616 32620 97.0 407235000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 381470 C3L-02648 LUSC Tumor_and_Normal 72 Male Other 3 Squamous cell carcinoma G3 Poorly differentiated Stage IIA Bulgaria Seventh Edition (2010) pT2 pN0 Staging Incomplete Staging Incomplete DACT3 NP_659493.2(pre=R,post=L) dapper homolog 3 isoform 1 GN=DACT3 AWASSWESEAAPEPAAPPAAPSPPDSPAEGR_AWAS[0.00]S[0.00]WES[0.00]EAAPEPAAPPAAPS[100.00]PPDS[0.00]PAEGR_1 1132.5197 3 32616 32620 97.0 407235000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 381471 C3N-01194 LUSC Tumor_and_Normal 69 Male Lower Lobe 4 Non-keratinizing squamous cell carcinoma G3 Poorly differentiated Stage IA Poland Seventh Edition (2010) pT2a pN0 No pathologic evidence of distant metastasis cM0 NP_001002858.1(pre=K,post=G) SLYYYIQQDTK_S[25.00]LY[25.00]Y[25.00]Y[25.00]IQQDT[0.01]K_1 654.0022 3 32632 32633 68.0 388644000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 381472 C3N-01020 LUSC Tumor_and_Normal 65 Male Other 4 Squamous cell carcinoma G3 Poorly differentiated Stage IB Vietnam Seventh Edition (2010) pT2a pN0 Staging Incomplete cM0 NP_001002858.1(pre=K,post=G) SLYYYIQQDTK_S[25.00]LY[25.00]Y[25.00]Y[25.00]IQQDT[0.01]K_1 654.0022 3 32632 32633 68.0 388644000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 381473 C3N-00497 LUSC Tumor_and_Normal 64 Female Middle Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIB Poland Seventh Edition (2010) pT2b pN1 No pathologic evidence of distant metastasis cM0 NP_001002858.1(pre=K,post=G) SLYYYIQQDTK_S[25.00]LY[25.00]Y[25.00]Y[25.00]IQQDT[0.01]K_1 654.0022 3 32632 32633 68.0 388644000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 383456 C3N-01194 LUSC Tumor_and_Normal 69 Male Lower Lobe 4 Non-keratinizing squamous cell carcinoma G3 Poorly differentiated Stage IA Poland Seventh Edition (2010) pT2a pN0 No pathologic evidence of distant metastasis cM0 UBAP2L NP_055662.3(pre=K,post=T) ubiquitin-associated protein 2-like isoform a GN=UBAP2L GGSTTGSQFLEQFK_GGS[0.03]T[0.03]T[1.49]GS[98.46]QFLEQFK_1 1013.0088 2 35656 35662 75.0 8029940.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 384542 C3N-01020 LUSC Tumor_and_Normal 65 Male Other 4 Squamous cell carcinoma G3 Poorly differentiated Stage IB Vietnam Seventh Edition (2010) pT2a pN0 Staging Incomplete cM0 ZC3H11A NP_001306167.1(pre=I,post=T) zinc finger CCCH domain-containing protein 11A isoform 1 GN=ZC3H11A NAADDDEDDDDQFSEEGDETK_NAADDDEDDDDQFS[100.00]EEGDET[0.00]K_1 966.7138 3 18334 18338 72.0 346275000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 385530 C3L-02648 LUSC Tumor_and_Normal 72 Male Other 3 Squamous cell carcinoma G3 Poorly differentiated Stage IIA Bulgaria Seventh Edition (2010) pT2 pN0 Staging Incomplete Staging Incomplete ELF3 NP_001107781.1(pre=K,post=T) ETS-related transcription factor Elf-3 GN=ELF3 ASWLGEQPQFWSK_AS[100.00]WLGEQPQFWS[0.00]K_1 701.3548 3 40773 40785 66.0 5604690.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 385531 C3N-01194 LUSC Tumor_and_Normal 69 Male Lower Lobe 4 Non-keratinizing squamous cell carcinoma G3 Poorly differentiated Stage IA Poland Seventh Edition (2010) pT2a pN0 No pathologic evidence of distant metastasis cM0 APOA4 NP_000473.2(pre=K,post=L) apolipoprotein A-IV precursor GN=APOA4 SELTQQLNALFQDK__0 698.3936 3 40786 40793 75.0 16344300.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 385532 C3N-01020 LUSC Tumor_and_Normal 65 Male Other 4 Squamous cell carcinoma G3 Poorly differentiated Stage IB Vietnam Seventh Edition (2010) pT2a pN0 Staging Incomplete cM0 APOA4 NP_000473.2(pre=K,post=L) apolipoprotein A-IV precursor GN=APOA4 SELTQQLNALFQDK__0 698.3936 3 40786 40793 75.0 16344300.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 385533 C3N-00497 LUSC Tumor_and_Normal 64 Female Middle Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIB Poland Seventh Edition (2010) pT2b pN1 No pathologic evidence of distant metastasis cM0 APOA4 NP_000473.2(pre=K,post=L) apolipoprotein A-IV precursor GN=APOA4 SELTQQLNALFQDK__0 698.3936 3 40786 40793 75.0 16344300.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 386532 C3N-01020 LUSC Tumor_and_Normal 65 Male Other 4 Squamous cell carcinoma G3 Poorly differentiated Stage IB Vietnam Seventh Edition (2010) pT2a pN0 Staging Incomplete cM0 PARP4 NP_006428.2(pre=R,post=C) poly [ADP-ribose] polymerase 4 GN=PARP4 TTPVDLCLLEESVGSLEGSR_T[0.00]T[0.00]PVDLCLLEES[0.00]VGS[100.00]LEGS[0.00]R_1 824.4017 3 43941 43948 80.0 105530000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 387529 C3L-03678 LUSC Tumor 49 Male White Not-Hispanic or Latino Lower Lobe 4 Squamous cell carcinoma G3 Poorly differentiated Stage IIIA United States Seventh Edition (2010) pT2a pN2 No pathologic evidence of distant metastasis cM0 HEXDC NP_001317471.1(pre=R,post=-) hexosaminidase D isoform 2 GN=HEXDC LQALLQDLSEVSAPPLPPTSPGRDVAQDP_LQALLQDLS[0.00]EVS[0.00]APPLPPT[50.00]S[50.00]PGRDVAQDP_1 1107.5739 3 47423 47436 43.0 6286880.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f01.raw CPTAC_Phosphoproteome 20200812 20221201 387530 C3L-02648 LUSC Tumor_and_Normal 72 Male Other 3 Squamous cell carcinoma G3 Poorly differentiated Stage IIA Bulgaria Seventh Edition (2010) pT2 pN0 Staging Incomplete Staging Incomplete HEXDC NP_001317471.1(pre=R,post=-) hexosaminidase D isoform 2 GN=HEXDC LQALLQDLSEVSAPPLPPTSPGRDVAQDP_LQALLQDLS[0.00]EVS[0.00]APPLPPT[50.00]S[50.00]PGRDVAQDP_1 1107.5739 3 47423 47436 43.0 6286880.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f02.raw CPTAC_Phosphoproteome 20200812 20221201 388527 C3N-01020 LUSC Tumor_and_Normal 65 Male Other 4 Squamous cell carcinoma G3 Poorly differentiated Stage IB Vietnam Seventh Edition (2010) pT2a pN0 Staging Incomplete cM0 NUCKS1 NP_073568.2(pre=K,post=E) nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 GN=NUCKS1 DDSHSAEDSEDEK_DDS[0.00]HS[0.05]AEDS[99.95]EDEK_1 667.9486 3 8620 8635 55.0 1027830000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f02.raw CPTAC_Phosphoproteome 20200812 20221201 388528 C3N-00497 LUSC Tumor_and_Normal 64 Female Middle Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIB Poland Seventh Edition (2010) pT2b pN1 No pathologic evidence of distant metastasis cM0 NUCKS1 NP_073568.2(pre=K,post=E) nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 GN=NUCKS1 DDSHSAEDSEDEK_DDS[0.00]HS[0.05]AEDS[99.95]EDEK_1 667.9486 3 8620 8635 55.0 1027830000.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f02.raw CPTAC_Phosphoproteome 20200812 20221201 390526 C3N-01194 LUSC Tumor_and_Normal 69 Male Lower Lobe 4 Non-keratinizing squamous cell carcinoma G3 Poorly differentiated Stage IA Poland Seventh Edition (2010) pT2a pN0 No pathologic evidence of distant metastasis cM0 NP_001245257.1(pre=A,post=E) SGSHSGSEEQLEATAR_S[1.91]GS[1.91]HS[96.19]GS[100.00]EEQLEAT[0.00]AR_2 678.952 3 12968 12974 85.0 82246700.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f02.raw CPTAC_Phosphoproteome 20200812 20221201 390527 C3N-01020 LUSC Tumor_and_Normal 65 Male Other 4 Squamous cell carcinoma G3 Poorly differentiated Stage IB Vietnam Seventh Edition (2010) pT2a pN0 Staging Incomplete cM0 NP_001245257.1(pre=A,post=E) SGSHSGSEEQLEATAR_S[1.91]GS[1.91]HS[96.19]GS[100.00]EEQLEAT[0.00]AR_2 678.952 3 12968 12974 85.0 82246700.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f02.raw CPTAC_Phosphoproteome 20200812 20221201 390528 C3N-00497 LUSC Tumor_and_Normal 64 Female Middle Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIB Poland Seventh Edition (2010) pT2b pN1 No pathologic evidence of distant metastasis cM0 NP_001245257.1(pre=A,post=E) SGSHSGSEEQLEATAR_S[1.91]GS[1.91]HS[96.19]GS[100.00]EEQLEAT[0.00]AR_2 678.952 3 12968 12974 85.0 82246700.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f02.raw CPTAC_Phosphoproteome 20200812 20221201 390529 C3L-03678 LUSC Tumor 49 Male White Not-Hispanic or Latino Lower Lobe 4 Squamous cell carcinoma G3 Poorly differentiated Stage IIIA United States Seventh Edition (2010) pT2a pN2 No pathologic evidence of distant metastasis cM0 NP_001245257.1(pre=A,post=E) SGSHSGSEEQLEATAR_S[1.91]GS[1.91]HS[96.19]GS[100.00]EEQLEAT[0.00]AR_2 678.952 3 12968 12974 85.0 82246700.0
19CPTAC_LSCC_Phosphoproteome_BI_20190831 19CPTAC_LSCC_P_BI_20190831_BD_f02.raw CPTAC_Phosphoproteome 20200812 20221201 391528 C3N-00497 LUSC Tumor_and_Normal 64 Female Middle Lobe 5 Keratinizing squamous cell carcinoma G2 Moderately differentiated Stage IIB Poland Seventh Edition (2010) pT2b pN1 No pathologic evidence of distant metastasis cM0 RANBP3 NP_015561.1(pre=R,post=E) ran-binding protein 3 isoform RANBP3-d GN=RANBP3 ENAAAESGSESSSQEATPEK_ENAAAES[20.00]GS[20.00]ES[20.00]S[20.00]S[20.00]QEAT[100.00]PEK_2 876.3731 3 14262 14265 57.0 101510000.0
상품 미리보기
연락처 및 데이터 관리
판매제공처 홈페이지 판매담당자 연락처 이메일
www.cellkey.co.kr 셀키 0507-1387-0260 sylee@cellkey.co.kr
제약 및 취소환불 규정
제약 및 취소/환불 규정 안내
데이터 상품은 디지털화된 상품의 특성상 반품, 취소, 환불 되지 않으나 데이터의 심각한 오류, 상이한 데이터에 한하여 구매자가 요구하는 경우 환불을 진행할 수 있습니다.
상품 Q&A

※ 본인의 글만 수정이 가능하며, 타인의 글에 댓글을 남길 수 없습니다.
※ 댓글이 달린 글은 수정과 삭제가 불가능합니다.

등록된 글이 없습니다.

닫기버튼
해당 문의 내역을 삭제하시겠습니까?

닫기버튼
해당 문의 내역을 삭제하시겠습니까?